Clinical Trials Logo

Diabetic Macular Edema clinical trials

View clinical trials related to Diabetic Macular Edema.

Filter by:

NCT ID: NCT03969303 Completed - Clinical trials for Diabetic Macular Edema

NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients

Start date: October 20, 2018
Phase:
Study type: Observational

Primary objective: To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula in AMD (Age-related Macular Degeneration) patients. Secondary objectives: 1. To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula in DME (Diabetic Macular Edema) patients. 2. To evaluate patient experience when self-operating the Notal-OCT V2.5.

NCT ID: NCT03956797 Completed - Clinical trials for Diabetic Retinopathy

Long Term Safety of Cooling Anesthesia for Intravitreal Injection

COOL-2
Start date: April 15, 2019
Phase: N/A
Study type: Interventional

The purpose of this clinical study is to evaluate the long term safety and efficacy of cooling anesthesia application to the eye as anesthesia for intravitreal injection using a novel cooling anesthesia device.

NCT ID: NCT03953807 Completed - Clinical trials for Diabetic Macular Edema

A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated

EYEberia
Start date: September 5, 2019
Phase: Phase 4
Study type: Interventional

This study will evaluate the efficacy and safety of OZURDEX in patients with Diabetic Macular Edema when used in a real world setting in Spain and Portugal.

NCT ID: NCT03927690 Completed - Clinical trials for Diabetic Macular Edema

Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema

Start date: May 24, 2019
Phase: Phase 2
Study type: Interventional

The primary objectives of this study were to evaluate the safety and efficacy of LKA651 in patients with macular edema from diabetic macular edema (DME),

NCT ID: NCT03927118 Completed - Clinical trials for Diabetic Macular Edema

Effect of Dexamethasone Implant on Optic Disc

Start date: February 1, 2018
Phase:
Study type: Observational

This study evaluates the effect of dexamethasone implant which is an intraocular corticosteroid on the optic nerve fibers. Retinal nerve fiber thicknesses and optic nerve head pitting rates were measured before and 6 months after the injection.

NCT ID: NCT03917472 Completed - Clinical trials for Diabetic Macular Edema

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

KINGFISHER
Start date: July 17, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the efficacy and safety of brolucizumab vs. aflibercept in the treatment of patients with visual impairment due to diabetic macular edema (DME).

NCT ID: NCT03889444 Completed - Clinical trials for Diabetic Macular Edema

Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)

Start date: January 15, 2019
Phase:
Study type: Observational

A retrospective, non-interventional, observational, multi-center, drug utilization study to be conducted in adult participants with visual impairment due to DME treated with Ozurdex implants in Germany and Switzerland from 1 January 2015 to 1 September 2017.

NCT ID: NCT03866746 Completed - Clinical trials for Diabetic Macular Edema

Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema

MPL
Start date: May 8, 2017
Phase: Phase 4
Study type: Interventional

prospective study evaluating the impact of subthreshold micropulsed laser on the number of Aflibercept injections when used as an adjuvant therapy in eyes with diabetic macular edema.

NCT ID: NCT03866473 Completed - Clinical trials for Diabetic Macular Edema

A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema

AE
Start date: April 10, 2019
Phase: N/A
Study type: Interventional

Randomized clinical trial evaluating the effect of photobiomodulation compared with sham on central subfield thickness (CST) in eyes with central-involved DME and good vision.

NCT ID: NCT03835884 Completed - Clinical trials for Diabetic Macular Edema

A Study Assessing AR-13503 Implant in Subjects With nAMD or DME

Start date: June 24, 2019
Phase: Phase 1
Study type: Interventional

First-in-Human Study of the Safety of AR-13503 Sustained Release Intravitreal Implant in Subjects with Neovascular Age-Related Macular Degeneration (nAMD) and Subjects with Diabetic Macular Edema (DME)